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ARTICLE
Cohesin cleavage by separase is enhanced by a
substrate motif distinct from the cleavage site
Laura E. Rosen1, Joseph E. Klebba1, Jonathan B. Asfaha1, Chloe M. Ghent1, Melody G. Campbell 2,
Yifan Cheng2 & David O. Morgan 1*
Chromosome segregation begins when the cysteine protease, separase, cleaves the
Scc1 subunit of cohesin at the metaphase-to-anaphase transition. Separase is inhibited prior
to metaphase by the tightly bound securin protein, which contains a pseudosubstrate motif
that blocks the separase active site. To investigate separase substrate specificity and reg-
ulation, here we develop a system for producing recombinant, securin-free human separase.
Using this enzyme, we identify an LPE motif on the Scc1 substrate that is distinct from the
cleavage site and is required for rapid and specific substrate cleavage. Securin also contains a
conserved LPE motif, and we provide evidence that this sequence blocks separase engage-
ment of the Scc1 LPE motif. Our results suggest that rapid cohesin cleavage by separase
requires a substrate docking interaction outside the active site. This interaction is blocked by
securin, providing a second mechanism by which securin inhibits cohesin cleavage.
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The protease separase initiates chromosome segregation inanaphase by cleaving the kleisin subunit (Scc1/Rad21) ofthe cohesin protein complex, allowing the duplicated
eukaryotic chromosomes to be segregated to opposite poles of the
cell1–3. Tight regulation of separase function is critical, as pre-
mature cleavage of cohesin can lead to chromosome loss and
genomic instability.
Separase is a large caspase-family cysteine protease (the human
protein is 2120 amino acids/233 kDa). Approximately one quarter
of human separase is comprised of the C-terminal protease
domain, which is conserved across eukaryotes and of which it is
possible to make a structural model based on homology to
orthologous structures4–7. The large N-terminal region is poorly
conserved and there is currently no detailed structural model of
this region in the human protein, although it is likely composed
of superhelical repeats like those seen in structures of separase
from budding yeast (Saccharomyces cerevisiae)5 and Cae-
norhabditis elegans6. Between the helical N-terminal region and
the C-terminal protease domain, human separase contains
regions that are predicted to be intrinsically disordered (Supple-
mentary Fig. 1a).
Separase cleavage sites have a minimal consensus motif of
ExxR, with cleavage occurring after the arginine1,2,8. Additional
local sequence preferences have been identified9, including an
acidic or phosphorylated residue immediately upstream of the
ExxR4,8,10,11. In the structure of the separase protease domain
from the filamentous fungus Chaetomium thermophilum, basic
and acidic binding pockets accommodate, respectively, the glu-
tamate and arginine of the consensus motif4. Two ExxR sites are
thought to be cleaved in the human Scc1 substrate8. Human
separase contains four ExxR sites in its central disordered region,
three of which are subjected to autocleavage upon separase acti-
vation12. After autocleavage, the N- and C-terminal domains of
separase remain bound, with no apparent loss of protease activ-
ity12. C. elegans separase has shorter but similarly located
intrinsically disordered regions, and its structure reveals that
association of the N- and C-terminal domains does not depend
on the disordered polypeptide chain between them6.
In early mitosis, separase is inhibited by a high-affinity inter-
action with the protein securin. Securin is thought to be intrin-
sically disordered when free in solution13, and the structures of
securin–separase complexes from budding yeast5 and C. elegans6
reveal that securin binds as an extended polypeptide along the
length of separase (Fig. 1a). A pseudosubstrate motif on securin
interacts with the separase active site4,14, presumably blocking
substrate interactions. Securin inhibition is relieved when the N-
terminal region of securin is ubiquitinated by the anaphase-
promoting complex/cyclosome (APC/C) in metaphase, targeting
it for destruction by the proteasome. Other vertebrate-specific
modes of separase regulation have been identified, including
inhibition by cyclin B-Cdk1 binding to separase in a manner
dependent on proline isomerization by Pin115, but the specific
molecular mechanism for this inhibition remains unknown.
The ExxR separase cleavage motif is ubiquitous in the pro-
teome, but very few of these motifs are known to be cleaved by
separase. Human Scc1 contains six ExxR motifs, for example, but
only two are cleaved in mitosis8. Local sequence context at the
cleavage site9, as well as its accessibility, are expected to determine
whether an ExxR motif is cleaved by separase. It also seems likely
that there are other as yet unidentified mechanisms governing
separase activity at the substrate level. Many proteases contain
exosites: protease regions distinct from the active site that bind
substrate sequences away from the cleavage site, thereby enhan-
cing reaction efficiency16. The only evidence for separase reg-
ulation by substrate engagement outside of the cleavage site is
that the securin-separase complex binds to DNA, helping to
localize it to chromosomes17. While this binding results in
increased cleavage of DNA-associated substrates, DNA does not
enhance the enzyme’s catalytic rate, and this interaction is too
general to explain the observed specificity of separase.
Separase was identified two decades ago1,2,18 and its central role
in cell division is well established. However, many basic questions
about its biochemical behavior and regulation remain unanswered,
in part because of the difficulty of producing active protein
amenable for biochemical and biophysical studies. It is well
established that soluble separase can only be obtained in recom-
binant systems by co-expression with securin, as securin appears
to be a co-translational separase-folding chaperone in addition to
being an inhibitor19,20. Therefore, production of active separase
typically begins with purification of the securin-separase complex,
from which securin is removed using the APC/C-proteasome
system (for human separase, an incubation with Xenopus egg
extract serves this purpose)15,21–23. While this protocol is suffi-
cient for certain experiments, it does not produce the quantities
and purity of protein needed for detailed biophysical studies.
In the present work, we used protein engineering to develop a
method for the generation of active separase starting from a set of
purified proteins. Using this active separase protein we discovered
that rapid cleavage of Scc1 requires a sequence motif in Scc1 that
is distinct from the cleavage motif, and which we predict interacts
with a docking site (exosite) on separase. We also show that
securin binding interferes with separase engagement of the sub-
strate docking motif, identifying a second mechanism by which
securin inhibits cohesin cleavage by separase.
Results
Strategy to produce human separase for studies in vitro. We
sought to produce active human separase protein at a purity and
scale sufficient for biophysical characterization. We focused on
expression in Sf9 insect cells with recombinant baculoviruses24.
First, we optimized heterologous expression of the securin-
separase complex by creating a gene fusion between the securin
C-terminus and the separase N-terminus, separated by a Gly-Ser
linker (Fig. 1b, Supplementary Fig. 1a). This fusion was inspired
by evidence that securin is a folding chaperone of separase19,20,25
and that these protein termini are co-localized24. Expression of
the fusion construct led to protein levels that were significantly
higher than those seen when securin and separase were co-
expressed in Sf9 cells (Supplementary Fig. 2). Yield was improved
further by N-terminal truncation of securin to remove its APC/C
degrons and by elimination of the separase autocleavage sites by
mutation (Supplementary Figs. 1a, 2).
Purified securin-separase (Fig. 1c) was characterized by
negative-stain electron microscopy (EM) (Fig. 1d, top, and
Supplementary Fig. 3). The sample was monodisperse, and class
averages were consistent with existing EM data for human
securin-separase6,24.
Human securin-separase has been demonstrated to bind DNA
in a non-sequence specific manner17. We evaluated whether our
securin-separase complex showed similar behavior. Binding of
securin-separase to a fluorescently-labeled 50 base-pair double-
stranded DNA molecule was evaluated by monitoring fluores-
cence polarization as a function of protein concentration (Fig. 1e).
The data fit well to a one site specific-binding model with a KD of
300 nM ± 100 nM. A DNA molecule with the same base
composition but different sequence yielded a similar KD (220
nM ± 60 nM). Because the separase–DNA interaction is not
sequence-specific, we expected that the measured affinity would
depend on length, with shorter DNA molecules exhibiting lower
affinities. Indeed, a 25 base-pair DNA molecule bound with a
lower affinity (KD= 800 nM ± 300 nM).
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Next, we sought to develop a method for activating separase
using purified components, rather than the traditional method of
using the APC/C-proteasome system in Xenopus egg extract.
Analogous to the proteasome, the ClpXP protein complex
consists of an unfoldase (the ATPase ClpX) and a peptidase
(ClpP)26. However, whereas the proteasome interacts with
ubiquitin to determine its targets, ClpXP recognizes specific
amino acid sequence motifs (degrons) on its protein targets26
(Fig. 1f). Additionally, E. coli ClpXP can be produced recombi-
nantly much more readily than the proteasome. There is also
precedent for the use of ClpXP to selectively remove a protein
from a protein complex27. We added a ClpXP degron at the N-
terminus of securin in our fusion construct, as well as a TEV
protease cleavage site in the linker between securin and separase
(Supplementary Fig. 1a). Following purification and cleavage with
TEV protease, incubation with a purified ClpXP variant with
enhanced activity towards this degron28 removed securin and
activated separase, as evaluated by cleavage of an Scc1 fragment
in vitro (Fig. 1g, Supplementary Fig. 4a). Separase also cleaved a
catalytically dead separase with intact autocleavage sites (Supple-
mentary Fig. 4b), consistent with previous evidence that separase
autocleavage can occur in trans29.
The ClpXP-activated separase was re-purified to remove TEV
protease, ClpXP, and any separase still bound by securin
(Supplementary Fig. 4c-e). This purification yielded sufficient
active separase to measure protein concentration spectroscopically
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Fig. 1 Production of active separase. a Cartoon of the securin-separase complex. The vertical dashed line indicates an approximate delineation between the
separase N-terminal helical domain (green) and C-terminal protease domain (blue) containing the active site (orange). The C-terminal region of securin
(dark purple) binds in an antiparallel fashion along the length of separase, and begins with the pseudosubstrate motif (red) bound in the separase active
site. The N-terminal region of securin (light purple) contains the APC/C degrons. b Diagram of the securin-separase fusion construct. Colors correspond to
a. Also depicted are the flexible Gly-Ser linker separating securin and separase (light gray) and the regions of human separase predicted to be intrinsically
disordered (IDR, dark gray). See Supplementary Fig. 1a for amino acid sequence. c Purified securin-separase fusion protein was analyzed by SDS–PAGE and
stained with Coomassie Blue, using molecular weight markers as indicated. d Purified securin-separase (top) and apo (active) separase (bottom) were
analyzed by negative-stain EM, and five representative class averages of each preparation are shown. Scale bar: 40 nM. e Securin-separase binding to
fluorescein-labeled DNA was evaluated by fluorescence polarization. Two 50 bp dsDNA molecules with the same base composition but different sequence
were tested, as well as a 25 bp molecule. Data points indicate means (±SD) of triplicate samples. Source data are provided in the Source Data file.
f Separase activation by the ubiquitin-proteasome system, whereby securin is tagged for degradation and removed, can be recapitulated using an N-
terminal ClpXP degron and the bacterial protease ClpXP. g Securin-separase fusion protein was incubated with TEV protease, ATP, and/or the ClpXP
ATPase as indicated, and separase activity was measured by cleavage of an 35S-labeled Scc1 fragment (residues 142–300) produced by translation in vitro.
h Michaelis–Menten analysis was performed with purified, active separase and the peptide DDREIMREGS, which includes cleavage site 1 in Scc1. The
peptide sequence was flanked by the MCA fluorophore and DNP quencher, and cleavage was monitored by an increase in fluorescence. Initial velocity was
normalized to enzyme concentration. Data points indicate means (±SD) of triplicate samples. Source data are provided in the Source Data file
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and to perform basic biophysical characterization. First, we used
Michaelis–Menten analysis to analyze the kinetics of the
interaction between the enzyme active site and a cleavage
substrate. These experiments were performed with a 10-amino
acid substrate peptide encompassing the best-characterized
separase cleavage site in human Scc1 (169EIMR, or site 1) flanked
by a FRET dye-quencher pair (Fig. 1h). The results fit well to a
standard Michaelis–Menten curve, yielding a KM of 70 ± 30 μM
and a kcat of 3 × 10−3 ± 1 × 10−3 s−1 (or 10 ± 3 h−1). These results
are consistent with a previous analysis of active separase reaction
kinetics30.
A 50 bp double-stranded DNA molecule did not have a
significant impact on peptide cleavage reaction kinetics (Supple-
mentary Fig. 5), consistent with previous evidence that DNA does
not affect the proteolytic activity of separase17.
Finally, we evaluated the apo separase using negative-stain EM
(Fig. 1d, bottom, and Supplementary Fig. 3). The sample was
monodisperse and indistinguishable from the securin-separase
complex at this resolution, indicating that separase does not
undergo a large-scale conformational change upon securin
removal. This result seems inconsistent with the previous
suggestion that securin removal causes a major conformational
change20. It should also be noted that the separase used here is the
S1126A variant, which is unable to undergo (phospho)seryl-prolyl
cis-trans isomerization15, so our results do not reflect any
conformational change that may be associated with isomerization.
Scc1 residues distant from cleavage site promote cleavage. Our
studies revealed that separase activity toward a minimal cleavage
site exhibits a very low catalytic rate31, suggesting that cleavage
rate is somehow enhanced in the cell. Though it is possible that
DNA binding (Fig. 1e) provides the extra affinity needed to boost
function in vivo, this would be highly nonspecific if this were the
only mechanism. We wanted to explore the possibility that
separase has a more specific substrate docking site.
The two separase cleavage sites in Scc1 are located within a
large region of predicted disorder between the terminal regions
that interact with the Smc3 and Smc1 subunits of cohesin32. To
investigate whether local sequence context accelerates the
cleavage of Scc1, we evaluated a series of Scc1 truncations with
an in vitro cleavage assay (Fig. 2a). Our starting point for this
assay was an internal Scc1 fragment (amino acids 142–400),
which was chosen after we observed more robust cleavage of Scc1
by separase when the terminal regions that interact with Smc3
and Smc1 were removed (Supplementary Fig. 4e compared to
Fig. 2b). This internal fragment does not contain site 2 (447EPSR),
and so it is cleavage at site 1 (169EIMR) that is being evaluated
here. However, even when site 2 is present, it does not appear to
be cleaved in this assay (Supplementary Fig. 4e), perhaps because
cleavage at site 2 requires other factors, such as adjacent
phosphorylation by Plk111.
We observed an abrupt reduction in cleavage of the Scc1
fragment upon C-terminal truncation from residues 275 to 250
(Fig. 2b), suggesting the presence of a separase-binding motif in
this region of Scc1. Note that this assay has lower sensitivity than
the above peptide cleavage assay, explaining why cleavage of the
smallest fragments is not observed even though they contain the
peptide sequence. Alanine scanning revealed that the most critical
residues for enhanced activity were a Leu-Pro sequence at
residues 255 and 256, with a contribution from Glu 257 (Fig. 2c).
We will refer to these residues as the LPE motif.
LPE motif promotes cleavage of separase biosensor in vivo.
Having demonstrated the importance of the LPE motif for
separase cleavage of Scc1 in vitro, we tested its importance
in vivo. We re-created a previously described separase biosensor
in human U2OS cells (Fig. 3a)33. With wild-type Scc1 (aa
142–467), efficient biosensor cleavage was observed during ana-
phase (Fig. 3b). Strikingly, the double point mutation 255Leu-
Pro→Ala-Ala reduced cleavage efficiency by 50% (Fig. 3c, d).
A biosensor containing a 10 amino acid deletion centered
on 255Leu-Pro yielded identical results as the double alanine
mutation, confirming that these two residues are key require-
ments for this interaction (Fig. 3c, d).
Although separase cleavage site 2 is present in this biosensor, it
was not cleaved in our assay, nor was it cleaved in a longer
version of the biosensor that extended 123 amino acids beyond
site 2 (Supplementary Fig. 6). Therefore, our observation that
255Leu-Pro promotes biosensor cleavage is specific to site 1.
Securin inhibits separase binding to LPE motif in Scc1. Our
results suggest that an exosite on separase interacts with the LPE
motif in Scc1, resulting in higher substrate affinity and more
efficient cleavage. An intriguing possibility is that securin binding
prevents this interaction, providing an additional mechanism by
which securin inhibits Scc1 cleavage. To address this possibility,
we created securin-separase fusion proteins in which securin was
truncated after the pseudosubstrate sequence that binds the
separase active site (Fig. 4a, Supplementary Figs. 1b, 7). The likely
pseudosubstrate sequence (113EIEKFFP) was identified previously
based on homology between human and C. thermophilum
securins4. We predicted that removal of the pseudosubstrate
motif would relieve the inhibition caused by securin directly
blocking the separase active site, but it would retain any effect of
securin binding elsewhere on separase. The fusion approach also
has the benefit of generating an extremely high local concentra-
tion of securin, compared to adding securin in trans. We tested
three securin truncations. These constructs contain securin resi-
dues 127–202, 138–202 or 160–202 covalently linked to separase
via a flexible glycine-serine linker; they will be referred to as
securinΔ127-separase, securinΔ138-separase, and securinΔ160-
separase, respectively (Fig. 4b, Supplementary Fig. 1b).
We first asked whether removal of the securin pseudosubstrate
region from the active site is sufficient to yield a cleavage-
competent active site. Michaelis-Menten analyses with the
peptide assay described earlier (Fig. 1g) showed that there are
no significant differences between the peptide cleavage activities
of the three securinΔ-separase proteins and separase with no
securin bound (Fig. 4c). The securin (93–202)-separase fusion
protein containing the pseudosubstrate motif was inactive in this
assay (Supplementary Fig. 8). These results confirm that the
pseudosubstrate sequence blocks the active site, and they also
suggest that securin binding outside the active site does not
impair catalysis through some allosteric mechanism, at least for
the portion of securin evaluated in these experiments.
We then tested whether the securinΔ-separase constructs were
able to cleave the Scc1 fragment in the gel-based assay, and
whether this cleavage was sensitive to mutation of the LPE motif
(Fig. 4d). SecurinΔ138-separase and securinΔ160-separase exhib-
ited efficient cleavage of the Scc1 substrate, and in both cases
activity was reduced by mutation of 255Leu-Pro. However,
securinΔ127-separase exhibited no cleavage activity in this assay.
This result strongly suggests that securin interferes with separase
binding to the LPE motif on Scc1, and that this interference is
localized to a region of securin between residues 127 and 138.
Intriguingly, this region of securin contains an LPE motif
(residues 130–132).
We developed an approach to investigate the importance of
130LPE for securin binding to separase. It is known that fungal
securin can be converted to a separase substrate by making
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mutations that convert the pseudosubstrate site into a cleavage
site4,14. We made the equivalent mutations in human securin
(118FP to RE) and used this securinRE mutant to test the
importance of 130LPE for securin engagement with separase. We
also tested an LP sequence a few residues further downstream
(139LP). In pilot experiments, a securinRE fragment containing
residues 93–202 was cleaved efficiently by separase, but mutation
of either LP sequence had no effect, presumably because this
fragment of securin makes too many contacts with separase for
individual point mutations to significantly weaken affinity. We
then tested a securinRE fragment containing residues 93–150.
This fragment was 50% cleaved by separase, and mutation of
130LP significantly impaired cleavage (Fig. 4e). Mutation of 139LP
had no effect, except when combined with mutation of 130LP.
These results suggest that the 130LPE motif of securin interacts
with separase.
Consistent with its importance in the regulation of separase,
the LPE sequence immediately downstream of the pseudosub-
strate motif is conserved in securin from vertebrates and in some
lower eukaryotes (Fig. 4f). Budding yeast securin carries a VPE
sequence at this location, and the crystal structure of the yeast
separase-securin complex indicates that the motif interacts with
the surface of separase adjacent to the catalytic domain5
(Supplementary Fig. 9). This region of separase is poorly
conserved in human separase, precluding straightforward pre-
diction of the LPE motif-binding site in the human protein.
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Fig. 2 Identification of a separase docking motif on Scc1. a Diagram of the Scc1 sequence, showing the locations of two separase cleavage sites, LPE motif,
and boundaries of truncated constructs evaluated in panels b and c. b 35S-labeled Scc1 fragments were incubated with active or inactive separase as
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of the relevant region of Scc1 is shown
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Discussion
Premature or partial cohesin cleavage can have disastrous con-
sequences for a cell undergoing mitosis, and separase must
therefore be tightly regulated. Several modes of separase regula-
tion have been identified, most notably the inhibition of separase
by the protein securin. Here, we identified a mechanism of
separase regulation at the level of the separase substrate Scc1. Our
evidence suggests that Scc1 contains a previously unknown
separase-binding motif (the LPE motif), distant from the cleavage
site, that enhances separase cleavage of Scc1.
Our results also clarify the mechanism by which securin
inhibits separase. The C-terminal separase-interacting segment of
securin binds along the length of separase in an antiparallel
fashion, starting with a pseudosubstrate motif bound in the
separase active site. Securin sequences downstream of this motif
are extended along the surface of the N-terminal domain of
separase5–7. It had been predicted but not previously
demonstrated that the presence of the securin pseudosubstrate
motif in the separase active site was sufficient to inhibit separase
catalytic activity. Our series of active separase constructs cova-
lently bound by truncated securin (securinΔ-separase) revealed
that removal of the pseudosubstrate motif alone allowed wild-
type rates of peptide substrate cleavage. Thus, the remaining
regions of securin do not inhibit the separase active site through
an allosteric mechanism. However, in the cleavage assay with
longer fragments of Scc1, these constructs showed that securin
binding interferes with separase engagement of the Scc1 LPE
motif, revealing a mechanism by which securin inhibits separase
activity toward cohesin (Fig. 4g).
We anticipate that cleavage of other separase substrates
depends on LPE or other docking motifs. In meiotic cells, the
Scc1-related protein Rec8 serves as the kleisin subunit of cohesin
and is cleaved by separase. The major separase cleavage site in
mouse Rec8, R45434, is followed by conserved LPE motifs about
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50 amino acids downstream (Supplementary Fig. 10a), hinting
that cleavage of Rec8 could depend on a downstream docking site
like the one we describe here. It remains to be seen if LPE or other
docking motifs are used to promote cleavage of cohesin across all
species. Budding yeast securin contains a VPE sequence down-
stream of its pseudosubstrate motif (Fig. 4f, Supplementary
Fig. 9), and yeast Scc1 contains an 376LPD sequence downstream
of its major cleavage site (265EQGR) (Supplementary Fig. 10b),
raising the possibility that docking is a deeply conserved feature
of separase function.
In vertebrate and yeast substrates, the LPE motif is located
50–100 amino acids downstream of the separase cleavage site
(Supplementary Figure 10), whereas the motif is only 11–14
residues downstream of the pseudosubstrate motif in securin
(Fig. 4f; Supplementary Fig. 9). Further studies will be required to
assess the role, if any, of the large inter-motif region that exists in
substrates but not in securin.
The LPE motif expands our understanding of the local context
that allows separase to preferentially cleave one ExxR sequence
over another. However, the sequence requirements for a separase
substrate remain poorly understood9. For example, in both our
in vitro and in vivo assays we observed cleavage only at site 1
even when an intact site 2 was present, and despite the fact that
there are conserved LPE motifs downstream of site 2 (Supple-
mentary Fig. 10a). There is evidence that phosphorylation near
site 2 (at serine 454) is required for cleavage11. However, when
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we moved site 2 to the local context of site 1 (i.e., changed the
two residues between E and R from those present at site 1 to
those present at site 2) we did not observe cleavage in our in vitro
assay (unpublished results). Additionally, when we moved an
extended sequence that encompasses site 1 into the context of
site 2, no cleavage was observed in our in vitro assay (unpub-
lished results). Further studies will therefore be required for a
complete understanding of sequence requirements for separase
cleavage.
In the course of this work, we made significant advances in the
production of active separase for studies in vitro. Previous studies
of active human separase required the APC/C and proteasome in
a crude cytoplasmic extract for removal and degradation of
securin from the securin-separase complex. Here, we were able to
produce active separase using simple, purified components by
employing ClpXP to remove securin. Additionally, our securinΔ-
separase protein fusion constructs provide a way to easily produce
constitutively active separase. We anticipate that these fusion
proteins will be useful for certain types of separase studies, such
as screens of small molecule separase inhibitors.
Identification of a separase docking motif on Scc1 means that
separase joins the growing list of proteases that are known to
employ exosite-substrate interactions distinct from the active site-
cleavage site interaction16. This additional interaction helps
explain the discrepancy between the slow separase cleavage
kinetics with the peptide substrate vs. the relatively fast kinetics
observed in the cell33. Indeed, proteases often cleave substrates
in vivo at rates that are orders of magnitude faster than those
observed with short peptide substrates encompassing only the
cleavage site16. It was previously demonstrated that DNA binding
helps localize separase to its substrate, which is also likely to help
explain the discrepancy between rates of cleavage in vitro and
in vivo17. The separase docking motif identified in our work
provides an additional, synergistic mechanism to enhance
separase engagement with its specific substrate.
Methods
Constructs, cloning and expression. Securin-separase fusion constructs were
cloned into a pFastBac HT A vector with an L21 leader sequence added imme-
diately upstream of the ORF35 (Supplementary Fig. 1a). DNA encoding the N-
terminal region of each protein (containing all or a subset of the following:
LambdaO ClpX sequence, 2x StrepII tag, securin, Gly-Ser linker, TEV protease
cleavage site, 3x FLAG tag) was codon optimized for insect cell expression and
synthesized as a gBlocks gene fragment by Integrated DNA Technologies (IDT).
Separase was amplified from a human cDNA library, and mutations were made
using either gBlocks gene fragments or fragment amplification and then assembled
using Gibson assembly. All constructs contained the S1126A mutation to prevent
(phospho)seryl-prolyl cis-trans isomerization and subsequent aggregation15.
Catalytically-dead separase constructs contained the C2029S mutation. For all
constructs with an intact active site, the autocleavage sites were mutated by
reversing the E and R residues for each of the three sites12. All constructs were
verified by full sequencing of the ~7000 bp ORFs. The resulting plasmids were
transformed into DH10Bac cells to generate bacmids through in vivo recombi-
nation. Purified bacmids were used to transfect Sf9 cells and generate P1 baculo-
virus. For protein expression, Sf9 cells were harvested 2–3 days after infection with
P2 virus. Protein expression was tested using Western blotting with anti-Strep II
(StrepMAB-Classic-HRP, IBA GmbH) or anti-FLAG (Anti-FLAG M2 Monoclonal,
Sigma) antibodies.
E. coli ClpX and ClpP-6His expression constructs were a generous gift from
Andreas Martin. ClpX is the full-length, AKH version, containing the mutation
R228A28, which we modified with a C-terminal 2x StrepII tag. TEV protease
construct pRK793 was a gift from David Waugh (Addgene plasmid # 8827; http://
n2t.net/addgene:8827; RRID:Addgene_8827)36. TEV protease and ClpX were
expressed in BL-21 DE3 E. coli at 30 °C for 4 h after induction with IPTG. ClpP was
expressed in a BL21 ClpP knockout strain at 25 °C for 4 h after induction
with IPTG.
The separase biosensor was generated as described by Shindo et al.33.
Specifically, Gibson cloning was performed to generate a final construct of pCMV-
H2B-mRuby2-Scc1(142–467)-mNeonGreen in a plasmid backbone containing
PGK-Neo. This was used as the template for all variations of the biosensor, which
were also generated using Gibson cloning.
Protein purification. Securin-separase fusion protein and ClpX protein were
purified on a StrepTrap column, with a lysis and wash buffer of 50 mM HEPES-
KOH pH 7.8, 300 mM KCl, 0.1 mM EDTA-KOH, 0.5 mM TCEP, 10% glycerol.
Proteins were eluted in one step in the same buffer containing 2.5 mM desthio-
biotin. Securin-separase was used for ClpXP activation (see below) or buffer
exchanged via PD-10 column into relevant buffers (see below), concentrated,
frozen in aliquots of 100 µl or less in liquid nitrogen (LN2), and stored at −80 °C.
Securin-separase used for negative-stain EM was additionally purified by size
exclusion using a Superose 6 10/300 GL column pre-equilibrated in the following
buffer: 25 mM HEPES pH 7.8, 75 mM KCl, 10 mM MgCl2, 0.5 mM TCEP, 5%
glycerol.
TEV protease and ClpP were purified on a HisTrap column. TEV protease
buffers were 50 mM Tris–HCl pH 8, 200 mM NaCl, 10% glycerol, 0.5 mM TCEP,
with 25 mM imidazole in the lysis and wash buffers and 800 mM imidazole in the
elution buffer. ClpP buffers were 50 mM HEPES pH 7.8, 100 mM KCl, 400 mM
NaCl, 10% glycerol, 0.5 mM TCEP, with 20 mM imidazole in the lysis and wash
buffers and 500 mM imidazole in the elution buffer. TEV protease, ClpX and ClpP
were each dialyzed overnight into 50 mM HEPES-KOH pH 7.5, 200 mM KCl, 25
mM MgCl2, 0.1 mM EDTA, 0.5 mM TCEP, 10% glycerol. After dialysis, precipitate
was pelleted by centrifugation and the supernatant frozen in aliquots of 250 µl or
less in LN2 and stored at −80 °C.
Separase activation and purification. Securin-separase fusion was purified as
described above. Eluted fractions were stored at 4 °C overnight, and then pooled
and concentrated to ~1 ml (~2.5 mg/ml). The concentrated protein was incubated
with 1 ml TEV protease (~2.5 mg/ml) and 10 µl Benzonase added to 11.1 ml of
25 mM HEPES pH 7.8, 100 mM KCl, 10 mM MgCl2, 10% glycerol for 1 h at 30 °C.
ClpX (1.7 ml, ~1.6 mg/ml) and ClpP (830 µl, ~2 mg/ml) were mixed and pre-
incubated at 25 °C for over 30 min. After the TEV protease incubation, 830 μl 100
mM ATP (in 25 mM HEPES pH 7.8, 100 mM KCl, 10 mM MgCl2, 10% glycerol)
was added to the securin-separase reaction mixture, followed by the pre-incubated
ClpXP. After 1.5 h at 30 °C, the mixture was filtered (0.2 μm) and run on a HisTrap
column to remove ClpP and TEV protease. The flow-through was pooled, con-
centrated to less than 2.5 ml, and run over a PD-10 column to change the buffer to
50 mM HEPES-KOH pH 7.8, 300 mM KCl, 0.1 mM EDTA-KOH, 0.5 mM TCEP,
10% glycerol. The protein was run on a StrepTrap column to remove ClpX and also
any separase still bound by securin. The flow-through was pooled and concentrated
to less than 1 ml, and loaded on a Superose 6 10/300 GL column pre-equilibrated in
the following buffer: 25 mM HEPES pH 7.8, 75 mM KCl, 10 mM MgCl2, 0.5 mM
TCEP, 5% glycerol. The separase peak was pooled, concentrated, frozen in aliquots
of 100 µl or less in LN2 and stored at −80 °C.
Electron microscopy. Separase and the separase-securin complex were diluted to a
nominal final concentration of 0.01 mg/ml in a buffer containing 25 mM HEPES-
KOH pH 7.8, 75 mM KCl, 10 mM MgCl2, 0.5 mM TCEP. For each sample, 3 µl was
applied to carbon-coated 200-mesh copper grids (Ted Pella, Redding, California)
which had been glow discharged for 30 s. Specimens were stained as previously
described37 with a solution containing 2% (w/v) uranyl formate. Data were
acquired with a Tecnai F20 Twin transmission electron microscope (FEI, Hillsboro,
Oregon) operating at 200 kV using SerialEM38 and a nominal range of 0.9–1.9 μm
under focus. Images were recorded on a TemCam-F816 CMOS camera (TVIPS,
Gauting, Germany) at a nominal magnification of ×50,000, which corresponds to
1.57 Å/px at the detector level. For the separase sample, 337 images were collected
(28,540 particles picked, ~80 particles per image) and for the separase-securin
complex 75 images were collected (26,077 particles picked, ~350 particles per
image). Immediately following image acquisition, micrographs were binned by two
to give a final pixel size of 3.14 Å/px. The CTF was estimated using GCTF39, and
particles were picked using a reference free routine as implemented in Gautomatch
(http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch). Data were processed in a
similar manner for each dataset, using Relion240 for 2D alignment and classifi-
cation into 100 classes.
Analysis of DNA binding by fluorescence polarization. Double-stranded, 5′-
fluorescein-labeled oligonucleotides were ordered from IDT. DNA was mixed with
a dilution series of securin-separase C2029S with the following final conditions:
1 nM DNA in 25 mM HEPES pH 7.8, 50 mM KCl, 5 mM MgCl2, 0.5 mM TCEP.
Samples were incubated 30 min at 25 °C prior to measurement. Fluorescence
polarization was measured on a Biotek Synergy H4 plate reader using excitation/
emission of 485/528 nm at a gain of 70. Signal from wells with no protein were used
to blank subtract the data, then the blank-subtracted fluorescence polarization was
normalized relative to the average value at the highest protein concentration. Data
were fit to a one-site binding model using GraphPad Prism.
Scc1 cleavage assay. 35S-methionine-labeled fragments of human Scc1 (and
securin; Fig. 4e) were produced in rabbit reticulocyte lysates using the TnT Quick
Coupled Transcription/Translation System (Promega). Variants were made by
QuikChange mutagenesis or Gibson cloning. All variants included an N-terminal
ZZ tag followed by a TEV protease cleavage site. Following translation in vitro,
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proteins were purified by immunoprecipitation on magnetic beads coated with
anti-ZZ IgG, and eluted by TEV protease. Active separase (~0.12 mg/ml) was
mixed 1:1 with purified Scc1 substrate and incubated for 1 h at 25 °C. Reaction
products were analyzed by SDS-PAGE with BioRad 4–20% TXP gels and visualized
with a Phosphorimager. Gels were also stained with Coomassie Blue to confirm
that enzyme concentration was the same in all reactions. This experiment was also
carried out in the condition where substrate was still bound to beads during
separase cleavage; i.e., no TEV protease was added until after separase cleavage.
The results were similar to those obtained in the presence of TEV protease.
For experiments with securin-free separase, experiments were performed either
with purified active separase or with activated separase but without downstream
purification to remove TEV protease and ClpXP. The presence of ClpXP had no
effect on the results. Additionally, in cases where ClpXP was present, apyrase was
used to remove residual ATP and thereby prevent ClpXP activity.
Peptide cleavage assay. The following peptide, containing Scc1 site 1, was
ordered from Genscript (>90% purity): Mca-DDREIMREGS-Dnp. Peptide was
dissolved in DMSO at a concentration of 47.5 mM. The peptide was serially diluted
into buffer (25 mM HEPES pH 7.8, 25 mM KCl, 0.5 mM TCEP) and mixed with
active separase (either securin-free separase purified after TEV protease/ClpXP
incubation or purified securinΔ-separase) at 0.1–0.5 mg/ml in the buffer: 25 mM
HEPES pH 7.8, 75 mM KCl, 10 mM MgCl2, 0.5 mM TCEP, 5% glycerol. The
reaction was immediately monitored by fluorescence on a Biotek Synergy H4 plate
reader, using an excitation of 328 ± 20 nm and an emission filter of 393 ± 20 nm
(gain of 75). Fluorescence was monitored for 1 h with 1 min reads. Data from 5 to
30 min was used for calculation of initial velocity.
To convert relative fluorescence units (RFU) to concentration of cleaved
substrate, a standard curve was generated by incubating peptide with 0.1 mg/ml
Trypsin for 2 h (to achieve full substrate cleavage) and then making a dilution
series (in triplicate). Fluorescence was measured on the same day and at the
same gain as in the kinetic assay. A plot of RFU vs concentration of cleaved
peptide was fit with a linear regression and the slope taken as the conversion
factor.
Separase concentrations were measured in triplicate on a Nanodrop
spectrophotometer by absorbance at 280 nm, and evaluated using a theoretical
extinction coefficient at A280 (calculated according to the number of Trp and Tyr
residues)41. The data for the Michaelis–Menten curves were normalized by
enzyme concentration. Data were fit to the Michaelis–Menten equation using
GraphPad Prism. Error for reported kcat incorporates the error in protein
concentration.
Biosensor expression and microscopy. Second-generation lentiviruses were
generated by transient co-transfection of 293T cells (a gift of Ron Vale, UCSF) in
DMEM+ 10% FBS, using a three-plasmid combination: one well in a 6-well dish
containing 1 × 106 293T cells was transfected using PEI with 0.5 µg lentiviral vector,
0.5 µg psPAX and 0.5 µg pMD2.G. Supernatants were collected every 24 h between
24 and 72 h after transfection and frozen at −80 °C.
For biosensor expression, U2OS cells (a gift of Ron Vale, UCSF) growing in
McCoy’s media+ 10% FBS were plated in a 6-well dish at 1 × 106 cells per well.
The following day, 0.5 ml lentivirus was added. After 48 h incubation, media was
removed and cells were washed with PBS. Next, fresh media with 500 µg/ml
Geneticin was added to the cells to select for transduced cells. After 1–2 weeks of
selection, cell lines were expanded for FACS analysis: cells were re-suspended in
FACS sorting buffer (PBS [Ca2+/Mg2+-free], 1 mM EDTA, 25 mM HEPES, 1%
FBS) and filtered through a 50 µM filter. These cells were then sorted on a Sony
SH800 Cell Sorter, selecting for cells with moderate levels of expression.
For microscopy, U2OS cells stably expressing the biosensor were plated in 24-
well glass-bottom dishes (Mattek P24G-1.0–10-F) and allowed to adhere
overnight. Media was removed and the cells were washed with PBS. Media was
then replaced with Opti-Mem supplemented with 10% FBS. Cells were imaged at
37 °C with 5% CO2 on a Nikon Ti inverted microscope equipped with CSU-22
spinning disk confocal and EMCCD camera. Mitotic cells were identified and
time points were taken every 2.5 min. For data analysis, images were processed
using ImageJ software as follows. Metaphase cells were identified by visual
inspection of DNA labeled with H2B-mRuby2. The mean fluorescence intensities
of GFP and RFP associated with DNA was then determined and the ratio of GFP
to RFP was calculated. The ratio of fluorescent intensities was normalized to
metaphase ratios, as it was assumed that the biosensor was intact at this stage. For
each post-metaphase time point, the GFP:RFP ratio was determined for the
brightest set of chromosomes and normalized against the GFP:RFP metaphase
timepoint.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1e, h, 3d, 4c, e, Supplementary Figs. 2, 4d, 5, and 8 are
provided as a Source Data file. All other relevant data are available within the Article and
Supplementary Information files or available from the authors.
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